Cullinan Therapeutics, Inc. (CGEM)
11.70
+0.39
(+3.45%)
USD |
NASDAQ |
Nov 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 19:03
Cullinan Therapeutics Gross Profit (Annual) : -0.311M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.311M |
| December 31, 2024 | -0.306M |
| December 31, 2023 | -0.31M |
| December 31, 2022 | -0.093M |
| Date | Value |
|---|---|
| December 31, 2021 | 18.89M |
| December 31, 2020 | -0.062M |
| December 31, 2019 | -0.07M |
| December 31, 2018 | -0.043M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Climb Bio, Inc. | -0.097M |
| MapLight Therapeutics, Inc. | -0.578M |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Oncolytics Biotech, Inc. | -0.07M |
| Sangamo Therapeutics, Inc. | 31.95M |